Position in DMAC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,294,569
+$1,010,477 QoQ
Shares Held
894,115
+14.6% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 87 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. DMAC ranks #222 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in DMAC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,294,569 | 894,115 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,284,092 | 780,516 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,083,469 | 764,255 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,890,189 | 711,818 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,457,576 | 630,148 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,196,657 | 315,741 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,660,226 | 305,751 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,286,153 | 306,958 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $698,819 | 236,888 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $662,680 | 239,235 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $621,329 | 218,778 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $564,447 | 218,778 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $798,638 | 184,870 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $282,851 | 184,870 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $292,113 | 184,870 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $229,671 | 185,219 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $357,584 | 177,022 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $437,145 | 174,858 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $625,755 | 167,763 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $672,729 | 167,763 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $594,382 | 133,569 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,175,482 | 128,468 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,051,507 | 103,699 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $265,686 | 62,662 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $390,935 | 56,412 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $161,067 | 57,524 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||